Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 7/20 | 1.00 |
| ▸ | HTR2A | P28223 | 7/20 | 1.00 |
| ▸ | HTR1A | P08908 | 7/20 | 1.00 |
| ▸ | HTR1D | P28221 | 6/20 | 1.00 |
| ▸ | HTR1B | P28222 | 4/20 | 1.00 |
| ▸ | HTR7 | P34969 | 3/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | HTR5A | P47898 | 2/20 | 1.00 |
| ▸ | HTR6 | P50406 | 2/20 | 1.00 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 1.00 |
| ▸ | HTR3B | O95264 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | HTR1E | P28566 | 1/20 | 1.00 |
| ▸ | HTR1F | P30939 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Serotonin SCHEMBL183226 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL30057954 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL1495 | 1.00 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL8208967 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29781387 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL25341783 | 0.98 | HTR2C (1.00) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL29669289 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL396997 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL3091827 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B | |
| Serotonin SCHEMBL1675866 | 0.98 | HTR2C (0.97) | HTR2CHTR2AHTR1AHTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8683 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | claimed |
| CN-122036690-A | Heteroaromatic ring compound, pharmaceutical composition and application thereof | 马应龙药业集团股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122017138-A | Comprehensive biomarker response Index (IBR) based photoaging micro-plastic composite toxicity detection and risk judgment method | 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) | 2026-05-12 | — | — | CN | claimed |
| US-12624036-B2 | Method of treating post-traumatic stress disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-12624037-B2 | Method of treating agitation, aggressive behavior, and impulse control disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4724052-A1 | COMPOSITIONS AND METHODS FOR TREATING HEMIPLEGIC MIGRAINE | Schedule 1 Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4299107-B1 | SYSTEMS FOR DELIVERING THERAPY USING AN AURICULAR STIMULATION DEVICE | SPARK BIOMEDICAL INC (US) | 2026-04-08 | — | — | EP | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20260085284-A1 | METHOD FOR TRANS-DIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS AND USE THEREOF | SHANGHAI GENEMAGIC BIOSCIENCES CO., LTD. (CN) | 2026-03-26 | — | — | US | claimed |
| US-20260069616-A1 | COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE | SCHEDULE 1 THERAPEUTICS, INC. (US) | 2026-03-12 | — | — | US | claimed |
| US-20220081409-A1 | PDE9 INHIBITOR AND USE THEREOF | TRANSTHERA SCIENCES (NANJING), INC. (CN) | 2022-03-17 | — | — | US | claimed |
| CN-114159438-A | Application of hypnagazine and derivatives thereof in preparation of medicaments for treating depression and prepared antidepressant medicaments | 首都医科大学附属北京安定医院 | 2022-03-11 | — | — | CN | claimed |
| EP-3958859-A1 | PREVENTING AND TREATING MALARIA | Shine, Ian Basil (US) | 2022-03-02 | — | — | EP | claimed |
| CN-114081175-A | Composition and application thereof in preparation of sleep improvement product | 内蒙古伊利实业集团股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-3955936-A1 | TREATMENT OF DEPRESSION AND OTHER VARIOUS DISORDERS WITH PSILOCYBIN | COMPASS Pathfinder Limited (GB) | 2022-02-23 | — | — | EP | claimed |
| EP-3953000-A1 | CELL MEMBRANE PERMEABILITY RESTORING THERAPY | Shine, Ian Basil (US) | 2022-02-16 | — | — | EP | claimed |
| WO-2022023759-A2 | METHODS OF PREPARING SOLID PARTICULATE MATERIALS | MICROPORE TECHNOLOGIES LIMITED (GB) | 2022-02-03 | — | — | WO | claimed |
| WO-2022023812-A1 | EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS | DIAMOND THERAPEUTICS INC. (CA) | 2022-02-03 | — | — | WO | claimed |
| CN-114007692-A | Methods and compositions for treating epilepsy | 加利福尼亚大学董事会 | 2022-02-01 | — | — | CN | claimed |
| WO-2022017440-A1 | 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 山东绿叶制药有限公司 | 2022-01-27 | — | — | WO | claimed |